Publications dans lesquelles il/elle collabore avec ALFREDO CARRATO MENA (29)

2021

  1. A multilayered post-GWAS assessment on genetic susceptibility to pancreatic cancer

    Genome Medicine, Vol. 13, Núm. 1

  2. Deciphering the complex interplay between pancreatic cancer, diabetes mellitus subtypes and obesity/BMI through causal inference and mediation analyses

    Gut, Vol. 70, Núm. 2, pp. 319-329

  3. Gallbladder disease and pancreatic cancer risk: a multicentric case-control European study

    European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP), Vol. 30, Núm. 6, pp. 423-430

2020

  1. Pancreatic Cancer Risk in Relation to Lifetime Smoking Patterns, Tobacco Type, and Dose-Response Relationships

    Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, Vol. 29, Núm. 5, pp. 1009-1018

2019

  1. Novel molecular characterization of colorectal primary tumors based on mirnas

    Cancers, Vol. 11, Núm. 3

  2. Pancreatic cancer and autoimmune diseases: An association sustained by computational and epidemiological case–control approaches

    International Journal of Cancer, Vol. 144, Núm. 7, pp. 1540-1549

2018

  1. A label free disposable device for rapid isolation of rare tumor cells from blood by ultrasounds

    Micromachines, Vol. 9, Núm. 3

  2. Risk of pancreatic cancer associated with family history of cancer and other medical conditions by accounting for smoking among relatives

    International Journal of Epidemiology, Vol. 47, Núm. 2, pp. 473-483

2017

  1. A systems approach identifies time-dependent associations of multimorbidities with pancreatic cancer risk

    Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 28, Núm. 7, pp. 1618-1624

  2. Reduced risk of pancreatic cancer associated with asthma and nasal allergies

    Gut, Vol. 66, Núm. 2, pp. 314-322

2016

  1. Prediction of non-muscle invasive bladder cancer outcomes assessed by innovative multimarker prognostic models

    BMC Cancer, Vol. 16, Núm. 1

2013

  1. EU pancreas: An integrated european platform for pancreas cancer research - From basic science to clinical and public health interventions for a rare disease

    Public Health Genomics, Vol. 16, Núm. 6, pp. 305-312

2010

  1. A polymeric chip for micromanipulation and particle sorting by ultrasounds based on a multilayer configuration

    Sensors and Actuators, B: Chemical, Vol. 144, Núm. 1, pp. 310-317

  2. Biallelic MYH germline mutations as cause of Muir-Torre syndrome

    Familial Cancer, Vol. 9, Núm. 2, pp. 151-154

  3. Circulating tumour cell analysis as an early marker for relapse in stage II and III colorectal cancer patients: A pilot study

    Clinical and Translational Oncology, Vol. 12, Núm. 2, pp. 142-147

2009

  1. TGFB1 and TGFBR1 polymorphic variants in relationship to bladder cancer risk and prognosis

    International Journal of Cancer, Vol. 124, Núm. 3, pp. 608-613

  2. The Int7G24A variant of transforming growth factor-beta receptor type I is a risk factor for colorectal cancer in the male Spanish population: A case-control study

    BMC Cancer, Vol. 9

  3. The TGFBR1*6A allele is not associated with susceptibility to colorectal cancer in a Spanish population: A case-control study

    BMC Cancer, Vol. 9

  4. Utility of p16 immunohistochemistry for the identification of Lynch syndrome

    Clinical Cancer Research, Vol. 15, Núm. 9, pp. 3156-3162

2007

  1. Post-transcriptional regulation of P-glycoprotein expression in cancer cell lines

    Molecular Cancer Research, Vol. 5, Núm. 6, pp. 641-653